Extended Data Table 1 Summary results of the PET and MRI comparisons for the three participant groups

From: Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)

  1. These analyses reveal that symptomatic mutation carriers show greater pathology than asymptomatic mutation carriers and non-carriers, as measured by atrophy, rates of glucose metabolism and Aβ accumulation. All depicted variables represent mean values with s.e. in parentheses. Statistical tests are one-way ANOVAs, and effect sizes represent partial η2.
Back to article page